Map of dopamine signaling in the neostriatum under normal and pathophysiological conditions
Map of dopamine signaling in the neostriatum under normal and pathophysiological conditions
批准号:
18300128
负责人:
NISHI Akinori
金额:
$10.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dopamine plays a central role in the regulation of psychomotor function in the brain. Many of the actions of dopamine are mediated through DARPP-32 (dopamine-and cAMP-regulated phosphoprotein of M_r 32 kDa). When DARPP-32 is phosphorylated on Thr34, it is converted into a potent inhibitor of protein phosphatase-1 (PP-1), and thereby controls the phosphorylation state and activity of many downstream physiological effectors. It is extremely important to identify signaling cascades activated by dopamine and other neurotransmitters under normal and pathophysiological conditions.In analysis of dopamine/DARPP-32 signaling under normal conditions, the phosphorylation site of DARPP-32 at Ser97 by CK2 was found to function as nuclear export signal. DARPP-32 at Ser97 is highly phosphorylated by CK2. The phosphorylated form of DARPP-32 enters into and is exported from nucleus. Phospho-Ser97 DARPP-32 is dephosphorylated by the dopamine D1 receptor/PKA/PP2A signaling cascade, and the dephospho-Ser97 DARPP-32 is not exported from nucleus and accumulates in nucleus. Since the dopamine D1 receptor/PKA/PP2A signaling cascade leads to phosphorylate DARPP-32 at Thr34, phospho-Thr34 DARPP-32 inhibits PP-1 and regulates the transcription of genes. In analysis of Mecp^<208/Y> mutant mice (a model mouse of Rett syndrome), we found that dopamine D1 receptor signaling is enhanced in neostriatal neurons after 20 weeks of age. In the study of methamphetamine sensitization, we found that the proportions of dopamine D1^<High> and D2^<High> receptors were increased in the striatum from MAP-sensitized rats, and that repeated administration of R-(+)-SKF38393 reversed the increased proportions of dopamine Dl^<High> and D2^<High> receptors in MAP-sensitized rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1074/jbc.m701046200
发表时间:
2007-06-01
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Nguyen, Chan, Nishi, Akinori, Bibb, James A.]
通讯作者:
Bibb, James A.
Expression of D1 but not D2 Dopamine Receptors in Striatal Neurons Producing Neurokinin B
产生神经激肽 B 的纹状体神经元中 D1 而非 D2 多巴胺受体的表达
DOI:
--
发表时间:
2007
期刊:
Eur J Neurosci 26
影响因子:
--
作者:
[Shuto T, Seeman P, Kuroiwa M, Nishi A., Stipanovich A, Shuto T, Ahn J-H, 西 昭徳, Nguyen C, Ahn J-H, Nguyen C, Sotogaku N, Kitaoka S, Sonomura T]
通讯作者:
Sonomura T
Protein kinase A activates protein phosphatase 2A by phosphorylation of the B568 subunit.
蛋白激酶 A 通过 B568 亚基的磷酸化激活蛋白磷酸酶 2A。
DOI:
--
发表时间:
2007
期刊:
Proc Natl Acad Sci USA 104
影响因子:
--
作者:
[Ahn. J-H, McAvoy T, Rakhilin SV, Nishi A, Greengard P, Nairn AC.]
通讯作者:
Nairn AC.
線条体ドーパミン情報伝達機構 : DARPP-32の役割
纹状体多巴胺信息传递机制:DARPP-32的作用
DOI:
--
发表时间:
2007
期刊:
久留米医学会雑誌 70
影响因子:
--
作者:
[Sonomura T, Nakamura K, Furuta T, Hioki H, Nishi A, Yamanaka A, Uemura M, Kaneko T., Nishi A, Ahn J-H, Sotogaku N, 西 昭徳]
通讯作者:
西 昭徳
メタンフェタミン逆耐性を消失させるドーパミンD1受容体刺激薬反復投与:線条体ドーパミン受容体親和性への影響
重复施用多巴胺 D1 受体兴奋剂可消除甲基苯丙胺反向耐受:对纹状体多巴胺受体亲和力的影响
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Kuroiwa M, Bateup HS, Greengard P, Nishi A., Kuroiwa M, 西 昭徳, 首藤 隆秀]
通讯作者:
首藤 隆秀
共 62 条
Map of dopamine signaling in the neostriatum
-
批准号:16300122
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2004
-
负责人:NISHI Akinori
-
依托单位:
Molecular mechanisms of the integration of inhibitory dopaminergic inputs and excitatory glutamatergic inputs in neostriatal neurons
-
批准号:14580754
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:NISHI Akinori
-
依托单位:
Molecular mechanisms to amplify dopamine signaling in neostriatal neurons
-
批准号:12680763
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2000
-
负责人:NISHI Akinori
-
依托单位:
Analysis of intracellular signaling cascades mediated by receptor activation and protein phosphorylation in neostriatal
-
批准号:10680727
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:NISHI Akinori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
从经方四逆散调控cAMP/PKA/DARPP-32通路抑制多巴胺系统亢进探讨“气机升降”理论在抽动障碍中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
DARPP-32促进EGFR:ERBB3二聚体形成介导转移性肺腺癌吉非替尼耐药的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:张永昌
-
依托单位:
NR2B受体与CAMKⅡ相互作用调控DARPP-32/FosB信号通路参与帕金森病异动症发生的机制研究
-
批准号:LY19H090008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:谢成龙
-
依托单位:
健脾止动汤抑制TS大鼠纹状体cAMP/PKA系统介导DARPP-32(Thr-34)磷酸化的机制研究
-
批准号:81403431
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:王道涵
-
依托单位:
社会挫败应激对6-OHDA所致皮质损伤青少年期小鼠在行为学变化和DARPP-32,GSK3表达的影响
-
批准号:81401112
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:黄光彪
-
依托单位: